Table 2 The genotypes and allele frequencies of nine polymorphisms screened for among patients and controls (P values are for allele frequencies)
| Mutation | Patients | Controls | P value | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Homo | Hetero | Wild | Allele frequency | Homo | Hetero | Wild | Allele frequency | ||
| MTHFR C677T | 13 | 33 | 56 | 28.9 | 12 | 25 | 40 | 31.8 | 0.554 |
| MTHFR A1298C | 20 | 48 | 34 | 43.1 | 16 | 29 | 32 | 39.6 | 0.503 |
|
FXIII Val34Leu | 4 | 22 | 76 | 14.7 | 1 | 21 | 55 | 14.9 | 0.952 |
|
β Fibrinogen − 455 G > A | 2 | 35 | 65 | 19.1 | 6 | 27 | 44 | 25.3 | 0.159 |
| Plasminogen activator inhibitor (4G) | 22 | 52 | 28 | 47.1 | 18 | 39 | 20 | 48.7 | 0.758 |
| Human Platelet Antigen 1 (HPA1) 1b | 4 | 27 | 71 | 17.1 | 1 | 14 | 62 | 10.4 | 0.07 |
| Angiotensin-converting Enzyme (ACE D) | 37 | 43 | 22 | 57.4 | 21 | 40 | 16 | 53.2 | 0.439 |
| Apo B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | – |
| Apo E allele (E4) | 1 | 9 | 92 | 5.4 | 0 | 9 | 68 | 5.8 | 0.854 |